Compare Amphastar Pharmaceuticals Inc (AMPH) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

XLU, the Utilities Select Sector SPDR ETF, trades at $45.41, up 0.62% on the day, with a bullish technical signal driven by moving averages. The ETF benefits from growing investor interest as AI-driven electricity demand transforms utilities into growth plays, with news highlighting long-term power agreements with tech firms. Key support sits at $45, while resistance is at $46. Recent dividend activity includes a $0.28 distribution scheduled for June 2026.

Outlook: XLU offers defensive exposure with upside from AI power demand, but risks include grid reliability and regulatory hurdles. Wall Street sentiment is positive due to earnings growth potential, though valuation metrics are unspecified. Investors should weigh stable dividends against infrastructure execution challenges in a shifting energy landscape.